EMA Tells Companies How To Boost Their Approval Chances Under PRIME

 
• By Neena Brizmohun

Companies find it challenging when it comes to preparing robust quality data packages for their marketing applications for investigational products that have made it onto the European Medicines Agency’s popular priority medicines scheme.

Medic staff at work in the laboratory. Background
PRIME helps companies optimize development plans for drugs for unmet medical needs • Source: Shutterstock

More from Product Reviews

More from Pink Sheet